INSIGHTS ON CLINICAL TRIAL DESIGN

• Evolving IRT For Today's Trials: Flexibility, Site Experience, And Integrated Workflow

  Interactive Response Technology is evolving beyond traditional randomization and trial supply management to help guide protocol workflows in increasingly complex studies.

• Blueprints For Success: Strategic Protocols And Partnerships In Clinical Trials

  By integrating patient feedback early in the design phase, trials can enhance recruitment and retention rates, ensuring both regulatory compliance and participant well-being.

• Five Predictions For Clinical Research In 2025

  In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.

• Pioneering Strategies For Early-Phase Oncology Trials

  As the field advances, adaptive methodologies and regulatory shifts redefine early-phase oncology trials, promoting efficiency, flexibility, and equitable access.

• From Bottlenecks To Breakthroughs: How AI Is Transforming Translation Timelines

  9/12/2025

  Take a deeper look at AI-enabled translations and uncover how they are able to drive a remarkable 43% reduction in overall translation timelines.

• Why Operational Design Determines Recruitment And Retention

  4/22/2026

  Patient recruitment challenges often receive the most attention in clinical trials, yet many enrollment and retention issues stem from operational friction embedded in study design.

• Scaling Investigational Drug Services: A Case Study in Overcoming Operational Bottlenecks

  8/20/2026

  Are operational bottlenecks holding back your research site? Explore a blueprint for automating investigational product workflows and giving staff time back for patient care.

• No More Back And Forth: Building eCOAs Right The First Time

  5/27/2025

  Clinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.

• The Implications Of Semaglutide's Connect To Increased Risk Of NAION

  2/18/2025

  Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).